Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
Rabbit Polyclonal Antibody against BRAF (Center)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This B-RAF antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 424-453 amino acids from the Central region of human B-RAF. |
Rabbit polyclonal B-RAF (Phospho-Ser446) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human B-RAF around the phosphorylation site of serine 446 (R-D-SP-S-D). |
| Modifications | Phospho-specific |
Rabbit polyclonal B-RAF (Ab-446) antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human B-RAF around the phosphorylation site of serine 446 (R-D-SP-S-D). |
Rabbit Polyclonal B-RAF Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human B-RAF |
Rabbit Polyclonal B-RAF (Ser446) Antibody (Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human B-RAF around the phosphorylation site of Serine 446 |
| Modifications | Phospho-specific |
Rabbit polyclonal B-Raf (Phospho-Thr753) antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human B-Raf around the phosphorylation site of threonine 753 (P-K-TP-P-I). |
| Modifications | Phospho-specific |
Rabbit polyclonal B-Raf (Ab-753) antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized non-phosphopeptide derived from human B-Raf around the phosphorylation site of threonine 735 (P-K-TP-P-I). |
Rabbit polyclonal B-RAF (Phospho-Thr599) antibody
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human B-Raf around the phosphorylation site of threonine 598 (L-A-TP-V-K). |
| Modifications | Phospho-specific |
Rabbit Polyclonal B-RAF Antibody
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against A synthesized peptide derived from human B-RAF |
Rabbit Polyclonal Phospho-B-RAF (Thr599) Antibody (Phospho-specific)
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthesized peptide derived from human B-RAF around the phosphorylation site of Threonine 599. |
| Modifications | Phospho-specific |
Chicken Polyclonal B-raf Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | B-raf antibody was raised against an 18 amino acid synthetic peptide near the center of human B-raf. |
Carrier-free (BSA/glycerol-free) BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
B-Raf Rabbit polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 280-460 of human B-Raf (NP_004324.2). |
| Modifications | Unmodified |
B-Raf Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 350-449 of human B-Raf (NP_004324.2). |
| Modifications | Unmodified |
B-Raf Rabbit polyclonal Antibody
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 350-449 of human B-Raf (NP_004324.2). |
| Modifications | Unmodified |
Phospho-B-Raf-S445 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic phosphorylated peptide around S445 of human BRAF (NP_004324.2). |
| Modifications | Phospho S445 |
Phospho-B-Raf-S728 Rabbit polyclonal Antibody
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | A synthetic phosphorylated peptide around S728 of human BRAF (NP_004324.2). |
| Modifications | Phospho S728 |
Phospho-BRAF (Thr401) Rabbit polyclonal Antibody
| Applications | IF, IP, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthesized peptide derived from human Phospho-B Raf (T401) (Phosphorylated) |
USD 420.00
4 Weeks
USD 420.00
4 Weeks
BRAF mouse monoclonal antibody, clone OTI5A9 (formerly 5A9)
| Applications | FC, IF, IHC, IP, WB |
| Reactivities | Human, Monkey, Mouse, Rat |
| Conjugation | Unconjugated |
Special Offer: Get a 15% discount on this product. Use code: "KO15".
USD 420.00
5 Days
USD 420.00
In Stock
Active filters
Target Symbol
- BRAF
Filter by
Category
Reactivities
Antibody Hosts
Isotypes
Clonalities
Conjugates
Knockout (KO) Validation
Modifications
Assay Types
Assay Platforms
Pathways
- Acute myeloid leukemia (100)
- Bladder cancer (100)
- Chemokine signaling pathway (100)
- Chronic myeloid leukemia (100)
- Colorectal cancer (100)
- Endometrial cancer (100)
- ErbB signaling pathway (100)
- Focal adhesion (100)
- Glioma (100)
- Insulin signaling pathway (100)
- Long-term depression (100)
- Long-term potentiation (100)
- MAPK signaling pathway (100)
- Melanoma (100)
- Natural killer cell mediated cytotoxicity (100)
- Neurotrophin signaling pathway (100)
- Non-small cell lung cancer (100)
- Pancreatic cancer (100)
- Pathways in cancer (100)
- Progesterone-mediated oocyte maturation (100)
- Prostate cancer (100)
- Regulation of actin cytoskeleton (100)
- Renal cell carcinoma (100)
- Thyroid cancer (100)
- Vascular smooth muscle contraction (100)
- mTOR signaling pathway (100)